Here’s What You Need to Know About the New Ankylosing Spondylitis Treatment

Basel, Switzerland, June 10, 2015 – Results from pharmaceutical giant, Novartis’ new one-year clinical trial called MEASURE 2 pivotal Phase lll were announced today. The randomized, double-blind, trial studied for…

Continue Reading Here’s What You Need to Know About the New Ankylosing Spondylitis Treatment